Follow The Filings

ESLA Estrella Immunopharma

Estrella Immunopharma earnings company data as of 7:30 PM ET 8/20

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q2 13 Aug EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by ESLA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ESLA insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Jiandong Xu CFO
    Buy
    $2,594 2,100 shares at $1.24
    Traded Sep 11, 2025–Oct 7, 2025 Filed Apr 29
    ↗

Also filed in the last 12 months, not counted as buying or selling: 2 option exercises.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 3.01 Filing Doc
8-K 3.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q QUARTERLY REPORT Filing Doc
8-K 5.07 Filing Doc
DEF 14A Filing Doc
10-Q QUARTERLY REPORT Filing Doc
SCHEDULE 13G — Filing Doc
10-K/A AMENDMENT NO. 1 TO FORM 10-K Filing Doc
10-K ANNUAL REPORT Filing Doc
424B3 PROSPECTUS Filing Doc
S-1/A REGISTRATION STATEMENT Filing Doc
S-1/A REGISTRATION STATEMENT Filing Doc
8-K 3.01 Filing Doc
424B5 PROSPECTUS SUPPLEMENT Filing Doc
8-K 1.01,3.02,7.01,9.01 Filing Doc
S-1 REGISTRATION STATEMENT Filing Doc
8-K 8.01,9.01 Filing Doc
10-Q QUARTERLY REPORT Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01 Filing Doc
8-K 5.02 Filing Doc
10-Q QUARTERLY REPORT Filing Doc
8-K 3.01 Filing Doc
8-K 8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.